At the Center of Health Care Policy Making

Andrew J. Stevens and Carole Longson

Medical Decision Making, 2013, vol. 33, issue 3, 320-324

Abstract: The UK’s National Institute for Health and Clinical Excellence (NICE), a world leader in health technology assessment (HTA), sits at the interface of a policy environment where everything is urgent and consensus between policy makers and stakeholders is sometimes difficult to attain. The majority of stakeholder challenges to NICE’s use of HTA concern the interpretation of evidence and the methodological rules applied by the appraisal committees. We discuss the most significant issues: choice of comparators; evidence synthesis and indirect comparison; parameter selection, especially for the valuation of quality of life; extrapolation beyond clinical trial data; and the level of the cost-effectiveness threshold.

Keywords: decision making; evidence-based medicine, technology assessment; National Institute of Health and Clinical Excellence; NICE; UK (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X13480563 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:33:y:2013:i:3:p:320-324

DOI: 10.1177/0272989X13480563

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().